Pharmaceutical Market Statistics, May 2013

Drug And Medication Innovation Trends In India: Starting A New Course ; Y.k. Hamied Steps Down As Managing Director. What Does It Mean For Cipla?

Company news
1 minute ago
by ProQuest Information & Learning

Tucked away neatly in a corner in the Mumbai office of Yusuf Khwaja Hamied is a desk stacked with journals , reference papers. Hamied, 76, subscribes to about 400 journals , spends close to 5 hours reading those every day. He makes some markings on those journals in red ink , sends them to the senior management of his pharmaceutical Industry player Cipla . Why? "Because I am seeing thin...

Industries : Drug and Medication
Countries : India

Drug And Medication Industry In India: Glaxo Baby Grows Up ; Remembered For Its Iconic Baby Foods, Glaxosmithkline Now Owns High Profile Brands In 2 Distinct Businesses...

Industry news
1 minute ago
by ProQuest Information & Learning

GlaxoSmithKline : Glaxo baby grows up ; Remembered for its iconic baby foods, GlaxoSmithKline now owns high profile brands in 2 distinct businesses - pharmaceuticals , consumer health-care. For India , 1919 was historic for many reasons, including the Jallianwala Bagh massacre , the start of Mahatma Gandhi's ascendance in the Indian freedom movement. For pharma Industry player GlaxoSmi...

Industries : Drug and Medication
Countries : India

Cancer Drug Technology Trends In The United States: Pitt Researchers Verify Cancer Drug Improves Alzheimer's Symptoms In Mice

Industry news
10 hours ago
by McClatchy-Tribune Information Services

2013-05-23 -- University of Pittsburgh researchers have confirmed that a federally-approved cancer drug reverses cognitive disabilities in mice with Alzheimer's disease. Rada Koldamova, associate professor at the Pitt graduate school of Public Health, called the results encouraging, but cautioned that the findings do not mean a cure is imminent. "We should not give false promises for somethi...

Industries : Drug and Medication
Countries : United States

Pharmaceutical Technology Trends In The United States And Georgia: Raptor Pharmaceutical's Procysbi? Receives Fda Approval For The Treatment Of Nephropathic Cystinosis - Final

Industry news
10 hours ago
by CQ Transcriptions LLC

Presentation OPERATOR: Good afternoon, ladies , gentlemen, , welcome to the Raptor Pharmaceutical FDA approved , commercial launch plans for PROCYSBI conference call. My name is Kelsey , I will be your coordinator for today. At this time all participants are in a listen-only mode, but following the presentation we will conduct a question-,-answer session. (Operator Instructions). As...

Industries : Pharmaceutical
Countries : United States, Georgia

Medicine Price Data In Pakistan And India: 200 Percent Rise In Some Medicine Prices Likely

Industry news
11 hours ago
by Plus Media Solutions Pakistan

ISLAMABAD : The Senate standing committee on National Regulations , Services is meeting tomorrow to finalise the controversial drug pricing mechanism that may result in a massive increase in prices of some medicines in the region. as reported by documents, a 200 pc hike in the prices of paracetamol , many other essential medicines is expected if the committee approves the new pricing f...

Industries : Drug and Medication
Countries : Pakistan, India

Antibiotic Technology Trends In The United States: Glaxo Unit To Work On Public-private Antibiotics Research

Industry news
12 hours ago
by McClatchy-Tribune Information Services

2013-05-23 --A local unit of drugmaker GlaxoSmithKline has a central role in a US Dollars 200 million public-private project announced Wednesday to develop antibiotics against biological terrorism , treat drug-resistant infections in health-care settings around the world. The U.S. government will pay Glaxo US Dollar1st million in the first 18 months, ,, if the project is on track, US Dollars 160 million more ov...

Industries : Drug and Medication
Countries : United States

Pathology Production Capacity In The United States: Ingram Micro Gives Back To Local Community At 20th Annual West Coast Charity Golf Tournament

Company news
12 hours ago
by Marketwire

SANTA ANA, CA -- (Marketwired) -- 05/23/13 -- Ingram Micro incorporated (NYSE: IM), the world's largest wholesale technology distributor , a global leader in IT supply-chain, mobile device lifecycle services , logistics solutions, today announced that it raised US Dollars 120000 at its 20th Annual West Coast Charity Golf Tournament, bringing the total amount raised over the past 20 years to more t...

Industries : Pathology
Countries : United States

Prostate Cancer Innovation Trends In The United States: Clinical Trial Tests Targeting Prostate Cancer Treatment

Company news
14 hours ago
by PR Newswire

ANN ARBOR, Mich. , 2013-05-23 /PRNewswire-USNewswire/ -- Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients ? the next question is to figure out how to match the right treatments with the right patients. A new clinical trial is testing whether targeting treatments to a genetic anomaly...

Industries : Pathology
Countries : United States

Drug And Medication Production Capacity: First Quarter 2013 Simcere Pharmaceutical Group Profits Conference Call - Final

Company news
15 hours ago
by CQ Transcriptions LLC

Presentation OPERATOR: Hello, everyone, , thank you for standing by for Simcere's Q1 2013 profits conference call. At this time, all participants are in listen-only mode. After management's prepared remarks, there will be a question , answer session. Today's conference is being recorded. If you have any objections, you may disconnect at this time. I would now like to turn th...

Industries : Drug and Medication

Therapy Industry In Canada And The United States: Nordion Arranges To Sell Targeted Therapies Business To Focus On Specialty Isotopes

Industry news
15 hours ago
by Business Monitor International

Espicom View: Nordion's Targeted Therapies business represents an attractive growth opportunity in the expanding field of global interventional oncology. Nordion built TheraSphere into a valuable product over the past decade , has positioned it for future growth , development. The product produces high gross margins of over 70 per cent, meaning that although BTG will be required to take ...

Industries : Therapy
Countries : Canada, United States

Mental Health Corporate Deals Activity In The United States: Mental Health America And U Squared Interactive Announce Strategic Partnership To Provide Online, Evidence-based Tools For Mental Health Issues

Company news
15 hours ago
by PR Newswire

ALEXANDRIA, Va. , 2013-05-23 /PRNewswire-USNewswire/ -- Mental Health America (MHA) , U Squared Interactive (U2) today announced a collaborative, private/nonprofit partnership to provide Americans online, evidence-based tools they can use to address challenging mental health issues such as depression , anxiety. U2 has developed a computerized cognitive behavioral therapy (CB...

Industries : Pathology
Countries : United States

Vaccine Innovation Trends In The United States: Aibiotech(r) Receives Subcontract Award From Dynport Vaccine Industry Player Llc, For Continued Development And Fda Approval Of A Nerve Agent Prophylactic

Company news
17 hours ago
by GlobeNewswire

RICHMOND, Va. , 2013-05-23 (GLOBE NEWSWIRE) -- AIBioTech is pleased to announce receipt of a firm fixed price subcontract from DynPort Vaccine Industry player LLC (DVC), a CSC Industry player, valued at nearly US Dollars 3 million for laboratory studies to support development of a biologic intended for use prior to an exposure to nerve agents. DVC issued this subcontract under its prime contract number W911QY-13...

Industries : Drug and Medication
Countries : United States

Vitamin D Industry Overview In The United States: Opko Surpasses 50 Percent Enrollment In 1st Phase 3 Trial Of Rayaldytm (ctap101 Capsules)

Industry news
17 hours ago
by Business Wire

MIAMI --(BUSINESS WIRE)-- OPKO Health, incorporated (NYSE: OPK), has surpassed 50 % enrollment in the 1st phase 3 trial of Rayaldy TM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) , vitamin D insufficiency. This trial is the 1st of 2 identical randomized, double-blind, placebo controlled, multi-site...

Industries : Vitamin and Supplement
Countries : United States

Drug And Medication Innovation Trends In The United States: Lpath Initiates Dosing In 1st Proof-of-concept Trial Of Anti-cancer Drug, Asonep

Company news
17 hours ago
by GlobeNewswire

SAN DIEGO , 2013-05-23 (GLOBE NEWSWIRE) -- Lpath, incorporated (Nasdaq:LPTN), the Market leader in bioactive lipid-targeted therapeutics,has initiated dosing in a Phase 2a single-arm trial where ASONEP? is being investigated as a treatment for renal cell carcinoma (RCC) in subjects that have failed the standard of care treatment with FDA -approved agents that block VEGF signaling (e.g. Sutent®...

Industries : Drug and Medication
Countries : United States

Drug And Medication Innovation Trends In Canada: New Report Confirms Innovative Pharmaceutical Market's Investment In Canada Is Chronically Underreported

Company news
18 hours ago
by Marketwire - Canada

OTTAWA, ONTARIO --(Marketwired - 2013-05-23 ) - For the 3rd consecutive year, a KPMG study commissioned by Canada's Research-Based Pharmaceutical Companies (Rx&D) has determined that research , development (R&D) investments made by Canada's innovative pharmaceutical Market continue to be consistently underreported, by approximately 34 per cent for 2012. The report released today, e...

Industries : Drug and Medication
Countries : Canada

Asthma Innovation Trends In The United States: New Asthma Drug Promising In Trials

Company news
18 hours ago
by McClatchy-Tribune Information Services

2013-05-23 --Human clinical trials show exciting promise for a new drug treatment for moderate , severe asthma, with further potential in treating severe eczema. Dupilumab, developed by Sanofi , Regeneron Pharmaceuticals incorporated , reduced asthma attacks by 87 % in people with a specific type of asthma, when compared with those given a placebo. Sally E. Wenzel -- a professor in the ...

Industries : Pathology
Countries : United States

Clinical Trial Innovation In Canada: Adhering To Good Clinical Practice, New Webinar Hosted By Xtalks

Industry news
18 hours ago
by PR Web

Toronto, Canada (PRWEB) 2013-05-23 During the conduct of research involving human subjects, it is critical to adhere to principles of good clinical practice (GCP) , human subject protection (HSP). Esteemed speaker Dr. Jeremy Lim , Fellow, Clinical Development at Novartis Pharmaceuticals , will help the audience: ? Understand the International Conference on Harmoniza...

Industries : Drug Discovery and Development
Countries : Canada

Heart Failure Innovation In The United States: Zensun Declares Positive Clinical Results For Neucardin? To Improve Heart Function And Reduce Mortality In Chronic Heart Failure Patients

Industry news
18 hours ago
by PR Newswire

SAN DIEGO , SHANGHAI , 2013-05-23 /PRNewswire/ -- Zensun Sci & Tech, Ltd., a biopharmaceutical Industry player based in Shanghai , San Diego , announced today positive results of 4 completed Phase 2 clinical trials including 3 double-blind, placebo-controlled studies conducted in China , Australia , interim results from the United States Phase 2 trial for Ze...

Industries : Pathology
Countries : United States

Breast Cancer Innovation Trends: Merrimack Pharmaceuticals Completes Enrollment In A Phase 2 Study Of Mm-121 In Combination With Exemestane In Breast Cancer

Company news
18 hours ago
by GlobeNewswire

CAMBRIDGE, Mass. , 2013-05-23 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, incorporated (Nasdaq:MACK) announced today that the last patient has been enrolled in a Phase 2 randomized, double blind clinical trial of MM-121 in combination with exemestane in postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) ,/or progesterone receptor positive (PR+), HER2-ne...

Industries : Pathology

Therapeutics Deals And Alliances In France: Miragen Therapeutics Achieves 1st Milestone In Strategic Alliance With Servier

Company news
18 hours ago
by Business Wire

Servier selects 3rd cardiovascular target triggering the 1st milestone under the collaboration SURESNES, France & BOULDER, Colo. --(BUSINESS WIRE)-- Servier , a privately-run French research-based pharmaceutical Industry player , a major player in Europe , emerging markets having expertise in the development of treatments for cardiovascu...

Industries : Therapy
Countries : France

Clinical Trial Innovation Trends: Tufts Csdd Study Finds Adoption Of Adaptive Clinical Trial Designs Is Increasing

Company news
18 hours ago
by Business Wire

Report Shows Growing Acceptance by Pharmaceutical Companies , Regulatory Agencies RESTON, Va. --(BUSINESS WIRE)-- Aptiv Solutions, a biopharmaceutical , medical device development services Industry player , pioneer in adaptive clinical trial design, simulation , execution, declares publication of a Tufts Center for the Study of Drug De...

Industries : Drug Discovery and Development

Pathology Innovation Trends In Japan And China: J&j's Janssen Poised To Continue Driving Growth, Outlines 10+ Potential New Product Filings By 2017

Company news
19 hours ago
by Benzinga

At a meeting today with Market analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ ) announced they anticipate submitting more than 10 new product filings , more than 25 significant brand line extensions by 2017. With a unique model of innovation, the Pharmaceuticals Sector of Johnson & Johnson (NYSE: JNJ ) has built an Market-leadin...

Industries : Pathology
Countries : Japan, World, China

Pathology Innovation Trends In Japan And China: Johnson & Johnson Pharmaceuticals Sector Poised To Continue Driving Growth With More Than 10 Potential New Product Filings By 2017

Company news
19 hours ago
by PR Newswire

NEW BRUNSWICK, N.J. , 2013-05-23 /PRNewswire/ -- At a meeting today with Market analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 new product filings , more than 25 significant brand line extensions by 2017. To view the multimedia assets associated with this release, please cl...

Industries : Pathology
Countries : Japan, World, China

Jennerex Completes Us Dollars 21.6 Million Private Placement

Company news
19 hours ago
by Marketwire

SAN FRANCISCO, CA -- (Marketwired) -- 05/23/13 -- Jennerex Biotherapeutics, incorporated , a private, clinical-stage biotechnology Industry player focused on the development , commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that it has completed a successful private placement financing of US Dollars 21.6 million . Proceeds from this financing will be u...

Industries : Pathology
Countries : South Korea

Pharmacies And Drug Stores Production Statistics In The United States: Medvantx Achieves Significant Milestone Of Managing Us Dollars 1.5 Billion In Prescription Medications And Completes Facilities Expansion While Upgrading To Offer Current Good...

Company news
19 hours ago
by PR Newswire

SAN DIEGO , 2013-05-23 /PRNewswire/ -- MedVantx, incorporated, the Industry player that has pioneered a unique direct to consumer pharmaceutical distribution channel announced today the Industry player has completed a major expansion of its home delivery platform to manage US Dollars 1.5 Billion in pharmaceutical products , the upgrade of its systems to offer a level of quality akin to cGMP facilities in its specialty...

Industries : Pharmacies and Drug Stores
Countries : United States

Drug Discovery And Development Production Statistics: Spectrum Pharmaceuticals To Present Corporate Update At The Deutsche Bank 38th Annual Health Care Conference In Boston On May 30th

Company news
19 hours ago
by Business Wire

HENDERSON, Nev. --(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Industry player with fully integrated commercial , drug development operations with a primary focus in hematology , oncology, today announced that an overview of the Industry player's business strategy , commercial , development-stage programs will be given at the Deutsc...

Industries : Drug Discovery and Development

Clinical Trial Innovation In South Korea: Pusan National University Declares Science Translational Medicine Publication Highlighting Landmark Demonstration Of Functional Anti-cancer Antibody Induction In Patients Following Jx-594 Treatment

Industry news
19 hours ago
by PR Newswire

BUSAN, South Korea , 2013-05-23 /PRNewswire/ -- Pusan National University Yangsan Hospital , in collaboration with SillaJen, incorporated , a private biotherapeutics , contract research Industry player focused on research , development of targeted biological products for cancer, announced today a publication reporting the induction of functional anti-cancer antibodies in patients treated...

Industries : Drug Discovery and Development
Countries : South Korea

Flu Industry In The United States: Sc Hospital Worker Rejected Flu Shot, Gets Benefit

Industry news
20 hours ago
by Associated Press, The

COLUMBIA, S.C. (AP) ? A former South Carolina hospital worker who refused a required flu shot is entitled to receive unemployment benefits thanks to a state appeals court. The South Carolina Court of Appeals ruled Wednesday that Pamela ...

Industries : Pathology
Countries : United States

Cancer Innovation Trends In The United Kingdom: Oncogenex Declares Plans For The Initiation Of The Cedar™ Clinical Trial Evaluating Ogx-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer

Company news
20 hours ago
by Canada Newswire

OGX-427 ORCA™ Program Expands to Include 2nd Phase 2 Trial in Patients with Advanced Lung Cancer BOTHELL, Wash. , VANCOUVER, British Columbia , 2013-05-23 /CNW/ - OncoGenex Pharmaceuticals, incorporated (NASDAQ: OGXI) today announced plans for the initiation of the Cedar™ clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in ...

Industries : Pathology
Countries : United Kingdom

Cancer Innovation Trends In The United Kingdom: Oncogenex Declares Plans For The Initiation Of The Cedar? Clinical Trial Evaluating Ogx-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer

Company news
20 hours ago
by PR Newswire

BOTHELL , Wash. , VANCOUVER, British Columbia , 2013-05-23 /PRNewswire/ -- OncoGenex Pharmaceuticals, incorporated (NASDAQ: OGXI) today announced plans for the initiation of the Cedar? clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer. This trial will be the se...

Industries : Pathology
Countries : United Kingdom